Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.
about
The Elusive Antifibrotic MacrophageHost responses in tissue repair and fibrosisThe phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosisIs Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.Evolving therapies for liver fibrosis.Up-regulated expression of extracellular matrix remodeling genes in phagocytically challenged trabecular meshwork cellsDocosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Association of age-dependent liver injury and fibrosis with immune cell populations.Involvement of cholangiocyte proliferation in biliary fibrosis.Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophagesCannabinoid receptor type I modulates alcohol-induced liver fibrosis.Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in miceSpecific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosisThe crucial role of cholangiocytes in cholangiopathiesPhenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Reversibility of Stricturing Crohn's Disease-Fact or Fiction?SP1 and UTE1 Decoy ODNs inhibit activation and proliferation of hepatic stellate cells by targeting tissue inhibitors of metalloproteinase 1.Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.Therapeutic targets in liver fibrosis.Epithelial-mesenchymal interactions in biliary diseasesTissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis.Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments.Delivery and targeting of miRNAs for treating liver fibrosis.Antifibrotic therapies in the liver.Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.Induction of experimental obstructive cholestasis in mice.Animal models of biliary injury and altered bile acid metabolism.Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytesFailure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation.Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies.Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis.Clearance of Apoptotic Cells by Tissue Epithelia: A Putative Role for Hepatocytes in Liver Efferocytosis.Optimized Mouse Models for Liver Fibrosis.
P2860
Q26776002-4B49D50D-829E-4C7F-97A6-B14063660FAAQ26852800-5BAEFC2C-FEE6-4C4C-88E4-9664A72E7D21Q27026037-F849E31A-AE62-4C12-888F-95E10F095553Q27330629-B769C650-5B03-4B38-AA0E-6149219394B9Q27692609-58D09520-BE8A-41EA-B846-2D3579F968DDQ30539166-AC630155-AE94-4423-9EF9-D43784C65FB8Q31056800-1EE1CFAD-1FA4-4D2A-BEEE-C7CA51574397Q33579420-D9A8C6F8-03E2-4230-9519-F9A3616A687CQ33818431-2CE4AB30-0CF8-4CD6-8093-7BDEC2527D12Q34118689-197AF567-C40A-49D3-833C-44091AB32643Q34992326-42A59B49-CE75-467B-8404-A4E84A6C5CBCQ35235774-44621987-5E55-4693-849E-F80E2FA03FA7Q35622533-47AAD442-EEBC-4243-BDEF-F4453C09A308Q35825861-01D26C24-F816-41E3-A999-C1B7E477F792Q35876795-554F477F-87D7-4698-AFDC-8AB78F2EB821Q36028696-161B4AEB-4BD0-4F5D-A94F-069BD90B5646Q36108921-356A0E48-1DB7-4B45-8DC1-D670242FA82BQ36113261-8E0B047E-BB97-4CB1-AD75-C9A9A41D8952Q36131170-CFF20DFE-338B-499D-99DD-3BB1913A7AF9Q36197335-8A715398-DB5E-4B60-B132-1D1B6B9FD3D4Q36373253-CAFA34F8-8CFE-47F6-A7D1-0D017753D3CBQ36890560-7A5F99B6-0C4A-4A8E-AD9D-B19C67AFED75Q37726957-84D6C62F-5F3D-4BFC-9870-6BC933C0D095Q37828321-14B86A37-0B20-49B8-BC2B-8B5EF995D85DQ37846143-DEB3317E-22B2-4B80-8329-76FE1F5962C3Q38003021-AFD3FAA6-E0A9-4541-B859-6E7DB202EAA8Q38068399-B76ED08D-3B4E-4467-8031-B083B1199B73Q38245905-94955A52-55DF-4672-B2F9-85FCAC4CF2F0Q38480164-D491836D-9929-4D93-AA00-9D1D5214F1C7Q38635618-DA88EB9C-2AA1-4B67-BBD8-5D1F5E2B3F3FQ39191568-1D71B19F-B16E-4EB0-B648-E42F11E4E4C1Q39436033-BE596D95-C2A9-4E92-B5D0-01F776657B6BQ41449567-52082E69-3F49-4647-9354-DB060B4237E0Q41519742-C366C489-3CAF-4F53-8746-9DA75CD4C5EFQ41816633-99BE9B85-9487-4BE8-94DB-CBA214444281Q41854134-B5F2634B-6C24-42A4-94CD-D82EEDE17953Q42983922-D1687FD3-0887-4FB2-8B9D-9E65FED07A28Q47274086-D130A04E-0FCA-4829-84D7-CCD0B8720CCCQ49691927-F08C7ECC-FD36-4A52-B38B-C24B3F07FCFEQ50219606-0585E815-F1BA-4707-9300-3595572B8BCB
P2860
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Macrophage-mediated phagocytos ...... experimental biliary fibrosis.
@ast
Macrophage-mediated phagocytos ...... experimental biliary fibrosis.
@en
type
label
Macrophage-mediated phagocytos ...... experimental biliary fibrosis.
@ast
Macrophage-mediated phagocytos ...... experimental biliary fibrosis.
@en
prefLabel
Macrophage-mediated phagocytos ...... experimental biliary fibrosis.
@ast
Macrophage-mediated phagocytos ...... experimental biliary fibrosis.
@en
P2093
P2860
P921
P356
P1476
Macrophage-mediated phagocytos ...... experimental biliary fibrosis
@en
P2093
Anisha K Sharma
Deanna Y Sverdlov
Detlef Schuppan
Eleonora Patsenker
Gunda Millonig
K Ramakrishnan Bhaskar
Lukas Krahenbuhl
Stephan Krahenbuhl
P2860
P304
P356
10.1152/AJPGI.00394.2009
P50
P577
2010-01-07T00:00:00Z